Momenta Pharmaceuticals Inc.

(MNTA) Trade

By |

Profile

Momenta is a biotechnology company based in Cambridge, Mass. Using technology developed at the Massachusetts Institute of Technology, it focuses on the characterization and development of innovative and complex generic drug molecules. Its first product was a bioequivalent generic version of Lovenox, sold through a partnership with Novartis. The company received an approval for the first generic version of Copaxone in early 2015, and has other innovative drugs under development.

Contact Information

Website: www.momentapharma.com
Email: IR@momentapharma.com
Main Phone: +1 617 491-9700
Address: 301 Binney Street
Address 2: Suite 3100, PO Box 49143
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Craig A. Wheeler
Employees: 131
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Momenta is a biotechnology company based in Cambridge, Mass. Using technology developed at the Massachusetts Institute of Technology, it focuses on the characterization and development of innovative and complex generic drug molecules. Its first product was a bioequivalent generic version of Lovenox, sold through a partnership with Novartis. The company received an approval for the first generic version of Copaxone in early 2015, and has other innovative drugs under development.

Contact Information

Website: www.momentapharma.com
Email: IR@momentapharma.com
Main Phone: +1 617 491-9700
Address: 301 Binney Street
Address 2: Suite 3100, PO Box 49143
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Craig A. Wheeler
Employees: 131
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 12.26 $ -0.13 (-1.05%)
Last Price 12.26 Change $ -0.13 Change % -1.05 Tick N/A
Bid N/A Bid Size 0.00 Ask 14.50 Ask Size 100.00
Open 12.42 High 12.57 Low 12.22 Prev Close 12.39
Last Trade Volume 282,996 52 Wk Hi 32.20 52 Wk Low 9.55
Market Cap 1.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 98,611,523.00 EPS (TTM) -2.08 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 48 108
Number of Buys 17 29
Number of Sells 31 79
Net Activity -26548 -47683
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Craig A. Wheeler 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 23 23 23 23
Low Target Price Estimate 15 15 15 16
Mean Target Price Estimate 18 18 18 20.67
Standard Deviation 4.36 4.36 4.36 4.04
Date of Most Recent Estimate 05/09/18 05/09/18 05/09/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 2 2 2
Moderate Buy 0 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 3 2.6 2.6 2.6